Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities.

MLA

Mahmoud, Ahmed M., et al. “Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities.” Oncologist, vol. 28, no. 4, Apr. 2023, pp. 297–308. EBSCOhost, https://doi.org/10.1093/oncolo/oyac263.

APA

Mahmoud, A. M., Nabavizadeh, R., Pessoa, R. R., Garg, I., Orme, J., Costello, B. A., Cheville, J., & Lucien, F. (2023). Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities. Oncologist, 28(4), 297–308. https://doi.org/10.1093/oncolo/oyac263

Chicago

Mahmoud, Ahmed M, Reza Nabavizadeh, Rodrigo Rodrigues Pessoa, Ishita Garg, Jacob Orme, Brian A Costello, John Cheville, and Fabrice Lucien. 2023. “Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities.” Oncologist 28 (4): 297–308. doi:10.1093/oncolo/oyac263.